Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 6/20 | 0.54 |
| ▸ | GNAO1 | P09471 | 6/20 | 0.54 |
| ▸ | GNAI1 | P63096 | 6/20 | 0.54 |
| ▸ | GUSB | P08236 | 2/20 | 0.52 |
| ▸ | EBP | Q15125 | 1/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | GBA1 | P04062 | 1/20 | 0.42 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.41 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28953723 | 1.00 | GNAI3 (0.54) | GNAI3GNAO1GNAI1GUSBEBP | |
| SCHEMBL11059811 | 1.00 | GNAI3 (0.54) | GNAI3GNAO1GNAI1GUSBEBP | |
| SCHEMBL5352409 | 1.00 | GNAI3 (0.54) | GNAI3GNAO1GNAI1GUSBEBP | |
| SCHEMBL4315182 | 1.00 | GNAI3 (0.54) | GNAI3GNAO1GNAI1GUSBEBP | |
| SCHEMBL6382988 | 1.00 | GNAI3 (0.54) | GNAI3GNAO1GNAI1GUSBEBP | |
| SCHEMBL1073381 | 0.97 | GNAO1 (0.52) | GNAI3GNAO1GNAI1GUSBEBP | |
| SCHEMBL3627046 | 0.97 | GNAO1 (0.52) | GNAI3GNAO1GNAI1GUSBEBP | |
| SCHEMBL4796729 | 0.97 | GNAI3 (0.50) | GNAI3GNAO1GNAI1GUSBEBP | |
| SCHEMBL11825391 | 0.97 | GNAI3 (0.50) | GNAI3GNAO1GNAI1GUSBEBP | |
| Hydrochloric Acid SCHEMBL1072740 | 0.95 | GNAI3 (0.50) | GNAI3GNAO1GNAI1GUSBEBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100107476-A1 | Compositions and Methods Including Hexahydrotriazines Useful as Direct Injection Fuel Additives | AFTON CHEMICAL CORPORATION (US) | 2010-05-06 | — | — | US | disclosed |
| US-20100107476-A1 | Compositions and Methods Including Hexahydrotriazines Useful as Direct Injection Fuel Additives | AFTON CHEMICAL CORPORATION (US) | 2010-05-06 | — | — | US | disclosed |
| US-7214842-B2 | Method for oligomerizing olefins | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-08 | — | — | US | disclosed |
| US-20050165266-A1 | olefin is brought into contact with a catalyst system comprising at least one transition metal complex with a polydentate complexing ligand and an alkylaluminoxane; transition metal complex is added continuously or in portions during the oligomerization. | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-28 | — | — | US | disclosed |
| US-20050119514-A1 | Oligomerization of olefins comprising at least three carbon atoms | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-02 | — | — | US | disclosed |
| US-6887958-B1 | Method for polymerizing olefins | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-03 | — | — | US | disclosed |
| US-6844290-B1 | Oligomerization catalyst | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-18 | — | — | US | disclosed |
| EP-1171483-B1 | METHOD FOR POLYMERISING OLEFINS | BASF AG (DE) | 2004-08-25 | — | — | EP | disclosed |
| EP-1171445-B1 | OLIGOMERISATION CATALYST | BASF AG (DE) | 2004-01-21 | — | — | EP | disclosed |
| EP-0620266-A2 | Removal of H2S from a hydrocarbon liquid | EXXON CHEMICAL PATENTS INC. (US) | 1994-10-19 | — | — | EP | disclosed |
| US-5354453-A | Removal of H2 S hydrocarbon liquid | EXXON CHEMICAL PATENTS INC. (US) | 1994-10-11 | — | — | US | disclosed |
| EP-0162938-B1 | USE OF ISOCYANATE OR ISOTHIOCYANATE POLYMERS FOR MAKING MICROCAPSULES | Schmidt, Joachim, Dr.-Med. (DE) | 1989-11-02 | — | — | EP | disclosed |
| EP-0162938-A1 | Use of isocyanate or isothiocyanate polymers for making microcapsules | Schmidt, Joachim, Dr.-Med. (DE) | 1985-12-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050119514-A1 | Oligomerization of olefins comprising at least three carbon atoms | OXER1, OSBP, COG7 | GNAI3 2518/4885GNAO1 1540/4885GNAI1 2242/4885 |
| US-20050165266-A1 | olefin is brought into contact with a catalyst system comprising at least one transition metal complex with a polydentate complexing ligand and an alkylaluminoxane; transition metal complex is added continuously or in portions during the oligomerization. | ALOX12, ALOX15B, ALOX15 | GNAI3 3639/4885GNAO1 1971/4885GNAI1 3405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.